共查询到17条相似文献，搜索用时 606 毫秒
1.
2.
3.
目的:观察甲钴胺穴位注射治疗糖尿病性皮肤瘙痒症效果。方法:100例糖尿病皮肤瘙痒症患者随机分为2组,治疗组50例,以当归注射液加甲钴胺注射液注射曲池、血海、足三里;对照组50例,口服盐酸西替利嗪片。比较2组疗效。结果:治疗组:痊愈:10例;显效:15例;有效:14例;无效:3例;总有效率:92.8﹪;对照组:痊愈:4例;显效:8例;有效:15例;无效:12例;总有效率:69.2﹪。2组总有效率比较:治疗组高于对照组(P0.01)。结论:以穴位注射治疗糖尿病皮肤瘙痒症效果良好。 相似文献
4.
5.
《黑龙江科技信息》2017,(17)
目的:观察补中益气汤和五苓散治疗膀胱过度活动症患者的疗效。方法:挑选纳入符合诊断标准OAB患者80例,随机分为治疗组40例和对照组40例。治疗组接受中西医结合疗法(补中益气汤合五苓散300ml/天),对照组用西医疗法(托特罗定片4mg/天),两组疗程均为4周。分别于治疗前、后以患者主观评价治疗受益程度与排尿日记记录(平均每次排尿量、24h平均排尿次数以及24h平均尿失禁次数)为疗效评判标准评价两组疗效。结果:治疗结束后患者24h平均排尿次数、平均每次尿量以及平均尿失禁次数均减少。治疗后两组患者均有明显的改善(P0.05),但治疗组改善的程度更为明显(P0.05),而且两组患者的主观受益人数和起效时间比较无统计学差异(P0.05)。证实补中益气汤合五苓散可明显改善OAB患者的症状。结论:采用补中益气汤合五苓散治疗女性OAB患者疗效可靠。 相似文献
6.
为探讨经尿道气化术治疗浅表性膀胱肿瘤的临床效果，对1998年10月－2000年11月间26例浅表性膀胱肿瘤患者采用经尿道气化术进行治疗。26例均顺利完成手术操作，手术平均时间40min，术中均未输血，未发生膀胱穿孔及大出血。术后随访2－18个月,3例复发。结果表明，经尿道膀胱肿瘤气化术（TVBT）具有快速、出血少、手术并发症少等优点，疗效满意。 相似文献
7.
8.
目的:探究艾灸气海、关元、膀胱腧穴位对预防TURP(经尿道前列腺电切术)术后并发膀胱痉挛的临床疗效观察。方法:选取行TURP术患者51例,随机分为两组,治疗组(常规治疗加穴位艾灸)25例和对照组(常规治疗)26例。治疗组于TURP术6时后开始艾灸气海、关元、膀胱腧三穴位,观察并比较两组术后72小时内冲洗液转清时间、冲洗时间、膀胱痉挛的次数与强度及术后疼痛,以及两组住院天数。结果:治疗组膀胱痉挛发生率41%,轻中重度分别为39%、2%、0%;对照组膀胱痉挛发生率53%,轻中重度分别为33%、12%、8%;两组在冲洗液转清时间、冲洗时间、住院天数均较治疗前有明显改善,其中以治疗组效果较为明显。结论:艾灸气海、关元、膀胱腧能有效预防TURP术后并发膀胱痉挛,减少术后膀胱痉挛引起的出血,减轻患者术后疼痛,缩短患者术后住院天数。 相似文献
9.
目的：探讨硬膜外注药后推拿治疗腰椎间盘突出症的疗效。方法：对30例腰椎间盘突出症患者采用硬膜外腔注入（利多卡因，地塞米松、VITB1、VITB12川芎嗪）药后推拿进行治疗。结果：痊愈18例，显效5例，好转6例，无效1例，总有效率96．9％，无一例病人出现不良反应。结论：硬膜外腔注药后推拿治疗腰椎间盘突出症疗效满意。 相似文献
10.
目的:对比身痛逐瘀汤加减与非甾体类抗炎药治疗腰椎间盘突出症的临床疗效。方法:检索维普资讯中文科技期刊数据库、CNKI中国期刊全文数据库,万方医学网数据库等。将符合纳入标准的7篇文献、774位患者的临床疗效进行Meta-分析。Meta-分析的软件为Cochrane协作网免费提供的Revman5.2专用软件。结果:提示身痛逐瘀汤治疗腰椎间盘突出症比非甾体类抗炎药治疗腰椎间盘突出症临床疗效好。结论:纳入资料Meta-分析后,同等基础条件下,治疗组中加入身痛逐瘀汤加减,对照组中加入单一或多种非甾体类抗炎药,治疗组可以显著提高治疗腰椎间盘突出症的有效率。 相似文献
11.
目的：观察中西医结合治疗椎基底动脉供血不足性眩晕的临床疗效。方法：将40例血管性眩晕患者采用简单随机分为两组,对照组单纯采用西药治疗,予654-2针剂10mg配氯化钠注射液100ml静滴,口服盐酸氟桂利嗪胶囊5mg,1日2次,1次1片;治疗组在此基础上配合血府逐瘀汤加味治疗。两组在用药1周后进行疗效对比观察。结果：中西医结合治疗组总有效率为95%,单纯西医治疗组总有效率85%,两组疗效比较有显著性差异（P＜0.05）。结论：血府逐瘀汤联合西药治疗椎基底动脉供血不足性眩晕疗效优于单纯西药治疗。 相似文献
12.
Ragaa H. M. Salama Tahia H. Selem Mohammed El-Gammal Abd-elmoneim A. Elhagagy Sally M. Bakar 《Indian journal of clinical biochemistry : IJCB》2013,28(3):265-271
The early diagnosis of bladder cancer is important for effective treatment of the disease. This study aimed to evaluate the nuclear matrix protein 22 (NMP 22), soluble epithelial cadherin (E-cadherin), cathepthin-D and total protein with clinico-pathological features of bladder cancer, and to determine the relation between each marker and tumor progression after treatment. The study includes 65 patients with bladder cancer, 14 benign urinary diseases and 11 healthy volunteers. Patients were categorized according to bilharzial infestation, T stage, tumor grade, size and the presence of lymph node metastasis. Forty patients were followed for disease progression after surgery. There was a significant increase of NMP22, E-cadherin, cathepthin-D and total protein detected in cancer group compared to healthy and benign groups. It was found that NMP 22 and E-cadherin had highest sensitivity (84.4, 76.9 %, respectively) while, total ddedprotein showed highest specificity (77.4 %). Tumor size correlated with urinary NMP22 (r = 0.3, p = 0.02), although, E-cadherin, cathepsin-D and total protein correlated with tumor size (r = 0.3, 0.28, 0.2; p = 0.01, p = 0.01, 0.04, respectively) and lymph node metastasis (r = 0.32, 0.34, 0.2; p = 0.003, 0.005, 0.04, respectively). Elevated pretreatment urinary NMP22, E-cadherin and total protein levels was associated significantly with bladder cancer recurrence (p = 0.02, 0.001, 0.005, respectively). In conclusion, determination of urinary NMP22, E-cadherin and total protein in bladder cancer patients or persons at risk of developing bladder cancer will help in early detection of the disease and prediction of recurrence. The use of a combination of tumor markers is markedly useful than the assessment of single one. 相似文献
13.
14.
[目的]制备恩诺沙星缓释注射液,并对其缓释性能进行评价。[方法]采用分散法制备恩诺沙星缓释注射液,考察制剂的沉降体积比,重新分散性,通针性,pH值和渗透压等各项质量指标,通过体外释放试验和家兔体内药动学实验评价制剂的缓释性能。[结果]制备的恩诺沙星缓释注射液稳定,具有良好的通针性,pH约为7.04,渗透压约为0.267osml/kg。体外试验中,恩诺沙星缓释注射液在0.5h的累积释放率仅为20%,直至12h累积释放率才达到80.2%。恩诺沙星缓释注射液主要的药物动力学参数是:清除率CL为1081.561±267.35 ml!h-1,Tmax为4h,体内平均滞留时间MRT为34.271±9.316 h。[结论]制备的恩诺沙星缓释注射液符合注射剂的要求,体内外试验均表明制剂具有一定的缓释效果。 相似文献
15.
M. S. Ghadge A. V. Sirsat M. S. Bhansali L. J. Desouza P Jagannath 《Indian journal of clinical biochemistry : IJCB》2001,16(1):60-64
Serum levels of leucine amino peptidase (LAP) was studied along with bilirubin, aspartate transaminase (AST), alanine transaminase
(ALT), gamma glutamyl transpeptidase (GGT), alkaline phosphatase (ALP) and the ratio of AST/ALT and GGT/AST in 25 healthy
subjects and 52 patients with hepatobiliary malignancies of which 12 were with hepatocellular carcinoma, 12 with liver metastasis,
6 with obstructive jaundice, 9 with carcinoma of gall bladder, 6 with carcinoma of pancreas and 7 with periampullary carcinoma.
24 Of the 52 patients studied had jaundice and 28 were without jaundice.
LAP as compared to the other enzymes AST, ALT, GGT, ALP and AST/ALT ratio and GGT/AST ratio showed 100% elevation in obstructive
jaundice, carcinoma of gall bladder and pancreas and periampullary carcinoma, 91.7% elevation in hepatocellular carcinoma
and 83.3% elevation in liver metastasis. On comparing the levels of these enzymes in non jaundiced and jaundiced groups, LAP
was elevated in both jaundiced and non jaundiced groups in 95.8% and 92.9% cases respectively whereas the other enzymes AST
showed increase from 67.9% to 100%, ALT from 21.4% to 83.3%, GGT from 71.4% to 95.4% and ALP from 82.1% to 100% in non jaundiced
and jaundiced groups respectively indicating that LAP rises in hepatic dysfunction due to hepatobiliary malignancy whereas
the other liver function enzymes showed increased hepatic dysfunction due to hepatobiliary malignancy with the onset of jaundice
thereby indicating that LAP is a better indicator of hepatobiliary malignancy as compared to other enzymes.
The quantitative methods used for determination are reliable, accurate, simple, rapid and cost effective and therefore have
better application in a clinical setting. 相似文献
16.
建立注射用盐酸头孢吡肟含量测定的RP-HPLC方法。ODS色谱柱250×4.6mm（i.d.）5μm;0.04mol/L醋酸铵（冰醋酸调节pH至5.0）-甲醇（92：8）为流动相,流速为1.0ml/min,检测波长为256nm。流速为1.0ml/min。盐酸头孢吡肟在10.5～84.0μg/ml浓度范围内,其峰面积与浓度呈良好线性关系（r=0.9993）,精密度RSD为0.5%。平均回收率为98.90%,RSD为0.34%,检测限为1.5ng。本法简便、快速、准确、专属性强,可用于注射用盐酸头孢吡肟的含量测定及有关物质检查。 相似文献
17.
目的：建立注射用维库溴铵有关物质的检测方法。方法：采用反相HPLC法,色谱柱为Agilent EclipseXD（BC-18,250×4.6mm,5μm）,流动相为：pH为6.5的18.0g·L^-1的四甲基氢氧化铵的溶液-甲醇-乙腈（50：250：700）,流速1.5ml·min-1,柱温40℃,进样量20μL,检测波长为210nm。稀释剂：乙腈：0.01mol·L^-1盐酸溶液（1：1）;结果：杂质A、杂质C和杂质E的检测限都为0.007%、杂质D和维库溴铵的检测限为0.006%,定量限为0.02%,柱温、流速、流动相比例经过微小变化不影响检测结果。结论：本方法灵敏度高,准确度高,可用于注射用维库溴铵有关物质的检测。 相似文献